Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | NT5E | P21589 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 4/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | CASP6 | P55212 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 6/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL838123 | 0.96 | TDP1 (0.49) | TDP1NT5ELMNAPKMPOLB | |
| SCHEMBL840742 | 0.94 | TDP1 (0.50) | TDP1NT5ELMNAPKMPOLB | |
| SCHEMBL840932 | 0.91 | TDP1 (0.51) | TDP1NT5ELMNAPKMPOLB | |
| SCHEMBL13772379 | 0.87 | TDP1 (0.44) | TDP1NT5ELMNAMAPTMEN1 | |
| SCHEMBL14845574 | 0.86 | TDP1 (0.48) | TDP1NT5ELMNAPKMPOLB | |
| SCHEMBL13366657 | 0.85 | TDP1 (0.42) | TDP1NT5EPKMMEN1RAB9A | |
| SCHEMBL14336345 | 0.85 | RAB9A (0.50) | TDP1NT5ELMNAPKMPOLB | |
| SCHEMBL842682 | 0.84 | TDP1 (0.41) | TDP1NT5EPKMALDH1A1HSD17B10 | |
| SCHEMBL842805 | 0.83 | NT5E (0.37) | TDP1NT5EPKMMEN1RAB9A | |
| SCHEMBL1450083 | 0.82 | RAB9A (0.44) | TDP1NT5EPKMPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8416376-B2 | Compensated in-plane switching mode liquid crystal display | CRYSOPTIX KK (JP) | 2013-04-09 | — | — | US | disclosed |
| US-8142863-B2 | Color liquid crystal display and compensation panel | Crysoptix, KK (JP) | 2012-03-27 | — | — | US | disclosed |
| US-7889297-B2 | Liquid crystal display operating in a vertically aligned mode | Crysoptix, KK (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20100149471-A1 | Compensated In-Plane Switching Mode Liquid Crystal Display | CRYSOPTIX KK (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100118241-A1 | Liquid Crystal Display Operating in a Vertically Aligned Mode | CRYSOPTIX KK (JP) | 2010-05-13 | — | — | US | disclosed |
| US-20090268136-A1 | Color Liquid Crystal Display and Compensation Panel | CRYSOPTIX KK (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090191394-A1 | Oarganic Compound, Optical Crystal Film and Method of Production Thereof | CRYSOPTIX K.K. (JP) | 2009-07-30 | — | — | US | disclosed |
| US-20090161037-A1 | Backlight Module and Liquid Crystal Display Incorporating the Same | CRYSOPTIX KK (JP) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090191394-A1 | Oarganic Compound, Optical Crystal Film and Method of Production Thereof | HCN3, CFH, KCNH1 | TDP1 4786/4885NT5E 976/4885LMNA 895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.